Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.
Zhejiang Yatai Pharmaceutical Co Ltd (002370) - Total Assets
Latest total assets as of September 2025: CN¥1.21 Billion CNY
Based on the latest financial reports, Zhejiang Yatai Pharmaceutical Co Ltd (002370) holds total assets worth CN¥1.21 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Yatai Pharmaceutical Co Ltd - Total Assets Trend (2006–2024)
This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zhejiang Yatai Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Yatai Pharmaceutical Co Ltd's total assets of CN¥1.21 Billion consist of 68.1% current assets and 31.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 53.1% |
| Accounts Receivable | CN¥127.82 Million | 9.1% |
| Inventory | CN¥70.13 Million | 5.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥69.81 Million | 5.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2006–2024)
This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Yatai Pharmaceutical Co Ltd's current assets represent 68.1% of total assets in 2024, an increase from 63.0% in 2006.
- Cash Position: Cash and equivalents constituted 53.1% of total assets in 2024, up from 27.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 8.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 9.1% of total assets.
Zhejiang Yatai Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Yatai Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Zhejiang Yatai Pharmaceutical Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Zhejiang Yatai Pharmaceutical Co Ltd generates 0.29x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Zhejiang Yatai Pharmaceutical Co Ltd generates $ 2.44 in net profit.
Zhejiang Yatai Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.27 | 1.32 | 4.37 |
| Quick Ratio | 9.61 | 1.22 | 4.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥736.53 Million | CN¥ 218.43 Million | CN¥ 983.32 Million |
Zhejiang Yatai Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Yatai Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.68 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | -1.9% |
| Total Assets | CN¥1.40 Billion |
| Market Capitalization | $628.52 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Yatai Pharmaceutical Co Ltd's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Yatai Pharmaceutical Co Ltd's assets decreased by 1.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Yatai Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total assets of Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.40 Billion | -1.93% |
| 2023-12-31 | CN¥1.43 Billion | -6.19% |
| 2022-12-31 | CN¥1.52 Billion | -5.41% |
| 2021-12-31 | CN¥1.61 Billion | -17.66% |
| 2020-12-31 | CN¥1.96 Billion | -13.76% |
| 2019-12-31 | CN¥2.27 Billion | -35.90% |
| 2018-12-31 | CN¥3.54 Billion | +24.26% |
| 2017-12-31 | CN¥2.85 Billion | +17.09% |
| 2016-12-31 | CN¥2.43 Billion | +18.01% |
| 2015-12-31 | CN¥2.06 Billion | +142.89% |
| 2014-12-31 | CN¥848.53 Million | +5.82% |
| 2013-12-31 | CN¥801.86 Million | -1.98% |
| 2012-12-31 | CN¥818.02 Million | -6.17% |
| 2011-12-31 | CN¥871.78 Million | +0.79% |
| 2010-12-31 | CN¥864.98 Million | +95.75% |
| 2009-12-31 | CN¥441.87 Million | +7.90% |
| 2008-12-31 | CN¥409.54 Million | +12.99% |
| 2007-12-31 | CN¥362.44 Million | +12.58% |
| 2006-12-31 | CN¥321.94 Million | -- |